Lee, S.-K.; Kim, M.S.; Kwon, S.-H.; Chung, B.Y.; Han, S.H.; Kim, H.J.
Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. J. Clin. Med. 2023, 12, 6326.
https://doi.org/10.3390/jcm12196326
AMA Style
Lee S-K, Kim MS, Kwon S-H, Chung BY, Han SH, Kim HJ.
Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Clinical Medicine. 2023; 12(19):6326.
https://doi.org/10.3390/jcm12196326
Chicago/Turabian Style
Lee, Soo-Kyung, Myoung Shin Kim, Soon-Hyo Kwon, Bo Young Chung, Se Hee Han, and Hyoung Jun Kim.
2023. "Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial" Journal of Clinical Medicine 12, no. 19: 6326.
https://doi.org/10.3390/jcm12196326
APA Style
Lee, S.-K., Kim, M. S., Kwon, S.-H., Chung, B. Y., Han, S. H., & Kim, H. J.
(2023). Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Clinical Medicine, 12(19), 6326.
https://doi.org/10.3390/jcm12196326
